D. Almenar

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro et al. · Journal of Clinical Oncology · 2005 · 231 citations

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

Carlos Camps, Bartomeu Massutí, Ángel Martín Jiménez et al. · Annals of Oncology · 2005 · 130 citations

Medicine, Metronomic Therapy, Bronchial Neoplasm +7

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Jorge Aparicio, Xavier García del Muro, Pablo Maroto et al. · Annals of Oncology · 2003 · 126 citations · Full text

Clinical Stage, Dual Policy, Surgical Oncology +8

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Annals of Oncology · 2014 · 122 citations · Full text

Prognostic Factors, Risk-adapted Studies, Urology +9

Preoperative Uracil, Tegafur, and Concomitant Radiotherapy in Operable Rectal Cancer: A Phase II Multicenter Study With 3 Years' Follow-Up

Carlos Fernández-Martos, Jorge Aparicio, Carles Bosch et al. · Journal of Clinical Oncology · 2004 · 70 citations